Hypoxia inducible-factor1α regulates the metabolic shift of pulmonary hypertensive endothelial cells

American Journal of Pathology

Volumn 176, Issue 3, 2010, Pages 1130-1138

  Fijalkowska, Iwona ^a   Xu, Weiling ^b   Comhair, Suzy A A ^b   Janocha, Allison J ^b   Mavrakis, Lori A ^b   Krishnamachary, Balaji ^a   Zhen, Lijie ^a   Mao, Thianzi ^a   Richter, Amy ^a   Erzurum, Serpil C ^b,c   Tuder, Rubin M ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Pulmonary Vascular Research Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; COPPER ZINC SUPEROXIDE DISMUTASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MANGANESE SUPEROXIDE DISMUTASE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; MICRORNA; NITRIC OXIDE;

ADULT; ARTICLE; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC PULMONARY ARTERY HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; LUNG; MALE; METABOLISM; MITOCHONDRION; PATHOLOGY; PULMONARY ARTERY; UMBILICAL VEIN;

ADULT; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG; MALE; MICRORNAS; MITOCHONDRIA; NITRIC OXIDE; PULMONARY ARTERY; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC; UMBILICAL VEINS;

EID: 77749291806     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090832     Document Type: Article

References (64)

1. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM: Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998, 101:927-934
2. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA: Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000, 67:737-744
3. The International PPH Consortium, Lane KB, Machado RD, Pauciulo.M.W., Thompson JR, Philips III JA, Loyd JE, Nichols WC, Trembath RC: Heterozygous germline mutations in BMPR2 encoding a TGF-B receptor cause familiar pulmonary hypertension. Nat Genet 2000, 26:81-84
4. Voelkel NF, Cool CD, Lee SD, Wright L, Geraci MW, Tuder RM: Primary pulmonary hypertension between inflammation and cancer. Chest 1999, 114:225S-230S
5. Rai PR, Cool CD, King JAC, Stevens T, Burns N, Winn RA, Kasper M, Voelkel NF: The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 178:558-564
6. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL: Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1 alpha. J Clin Invest 1999, 103:691-696
7. Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, Collen D, Carmeliet P: Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 2003, 111:1519-1527
8. Semenza GL: Life with oxygen. Science 2007, 318:62-64
9. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732
10. Warburg O, Posener K, Negelein E: Ueber den Stoffwechsel der Carcinomzelle. Biochem 1924, Z152:319-344
11. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P: Loss of HIF-2[alpha] and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002, 8:702-710
12. Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995, 95:1798-1807
13. Tuder RM, Chacon M, Alger LA, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci MW, Semenza GL, Yacoub M, Polak JM, Voelkel NF: Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001, 195:367-374
14. Bonnet S, Michelakis ED, Porter CJ, ndrade-Navarro MA, Thebaud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry S, Weir EK, Archer SL: An abnormal mitochondrial-hypoxia inducible factor-1 alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats - similarities to human pulmonary arterial hypertension. Circulation 2006, 113:2630-2641
15. Xu W, Koeck T, Lara AR, Neumann D, DiFilippo FP, Koo M, Janocha AJ, Masri FA, Arroliga AC, Jennings C, Dweik RA, Tuder RM, Stuehr DJ, Erzurum SC: Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci USA 2007, 104:1342-1347
16. Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, Drazba J, nand-Apte B, Erzurum SC: Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007, 293:L548-L554
17. Girgis RE, Champion HC, Diette GB, Johns RA, Permutt S, Sylvester JT: Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy. Am J Respir Crit Care Med 2005, 172:352-357
18. Kaneko FT, Arroliga AC, Dweik RA, Comhair SA, Laskowski D, Oppedisano R, Thomassen MJ, Erzurum SC: Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med 1998, 158:917-923
19. Machado RF, Londhe Nerkar MV, Dweik RA, Hammel J, Janocha A, Pyle J, Laskowski D, Jennings C, Arroliga AC, Erzurum SC: Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. Free Radic Biol Med 2004, 37:1010-1017
20. Ozkan M, Dweik RA, Laskowski D, Arroliga AC, Erzurum SC: High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung 2001, 179:233-243
21. Xu W, Kaneko FT, Zheng S, Comhair SA, Janocha AJ, Goggans T, Thunnissen FB, Farver C, Hazen SL, Jennings C, Dweik RA, Arroliga AC, Erzurum SC: Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 2004, 18:1746-1748
22. Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF: Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 2004, 169:764-769
23. Grobe AC, Wells SM, Benavidez E, Oishi P, Azakie A, Fineman JR, Black SM: Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol - Lung Cell MPH 2006, 290:L1069-L1077
24. Liu JQ, Zelko IN, Erbynn EM, Sham JS, Folz RJ: Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol 2006, 290:L2-L10
25. Wedgwood S, Black SM: Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal 2003, 5:759-769
26. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A: Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004, 43:5S-12S
27. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43-S54
28. Richter A, Yeager ME, Zaiman A, Cool CD, Voelkel NF, Tuder RM: Impaired transforming growth Factor β signaling in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2004, 170:1340-1348
29. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-9826
30. Arsham AM, Plas DR, Thompson CB, Simon MC: Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J Biol Chem 2002, 277:15162-15170
31. Comhair SAA, Xu W, Ghosh S, Thunnissen FBJM, Almasan A, Calhoun WJ, Janocha AJ, Zheng L, Hazen SL, Erzurum SC: Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol 2005, 166:663-674
32. Tuder RM, Groves BM, Badesch DB, Voelkel NF: Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994, 144:275-285
33. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000, 60:7075-7083
34. Dorfmuller P, Perros F, Balabanian K, Humbert M: Inflammation in pulmonary arterial hypertension. Eur Respir J 2003, 22:358-363
35. Masri FA, Comhair SA, Dostanik-Larson I, Kaneko FT, Dweik RA, Arroliga AC, Erzurum SC: Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. Clin Transl Sci 2008, 1:99-106
36. Kaewpila S, Venkataraman S, Buettner GR, Oberley LW: Manganese superoxide dismutase modulates hypoxia-inducible factor-1 alpha induction via superoxide. Cancer Res 2008, 68:2781-2788
37. Wang M, Kirk JS, Venkataraman S, Domann FE, Zhang HJ, Schafer FQ, Flanagan SW, Weydert CJ, Spitz DR, Buettner GR, Oberley LW: Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. Oncogene 2005, 24:8154-8166
38. 2 sensing. J Biol Chem 2000, 275:25130-25138
39. Mateo J, Garcia-Lecea M, Cadenas S, Hernandez C, Moncada S: Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways. Biochem J 2003, 376:537-544
40. Murphy MP: Does interplay between nitric oxide and mitochondria affect hypoxia-inducible transcription factor-1 activity? Biochem J 2003, 376:e5-e6
41. Coulet F, Nadaud S, Agrapart M, Soubrier F: Identification of hypoxiaresponse element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 2003, 278:46230-46240
42. Cracowski JL, Cracowski C, Bessard G, Pepin JL, Bessard J, Schwebel C, Stanke-Labesque F, Pison C: Increased lipid peroxidation in patients with pulmonary hypertension. Am J Respir Crit Care Med 2001, 164:1038-1042
43. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 2000, 95:189-197
44. Palmer LA, Gaston B, Johns RA: Normoxic stabilization of hypoxiainducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol 2000, 58:1197-1203
45. Metzen E, Zhou J, Jelkmann W, Fandrey J, Brune B: Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell 2003, 14:3470-3481
46. Callapina M, Zhou J, Schmid T, Kohl R, Brune B: NO restores HIF-1 alpha hydroxylation during hypoxia: role of reactive oxygen species. Free Rad Biol Med 2005, 39:925-936
47. Agani FH, Pichiuli P, Chavez JC, LaManna JC: The role of mitochondria in the regulation of the hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem 2000, 275:35863-35867
48. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT: Mitochondrial reactive oxygen species trigger hypoxiainduced transcription. Proc Natl Acad Sci USA 1998, 95:11715-11720
49. Schroedl C, McClintock DS, Budinger GRS, Chandel NS: Hypoxic but not anoxic stabilization of HIF-1 alpha requires mitochondrial reactive oxygen species. Am J Physiol -Lung Cell MPH 2002, 283:L922-L931
50. Hagen T, Taylor CT, Lam F, Moncada S: Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 2003, 302:1975-1978
51. Liu Y, Christou H, Morita T, Laughner E, Semenza GL, Kourembanas S: Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J Biol Chem 1998, 273:15257-15262
52. Quintero M, Colombo SL, Godfrey A, Moncada S: Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci USA 2006, 103:5379-5384
53. Vinogradov AD, Grivennikova VG: Generation of superoxide-radical by the NADH:ubiquinone oxidoreductase of heart mitochondria. Biochemistry (Mosc) 2005, 70:120-127
54. Li M, Chiu JF, Mossman BT, Fukagawa NK: Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats. J Biol Chem 2006, 281:40429-40439
55. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM: Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001, 88:e8-e11
56. Cool CD, Rai MD, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, Voelkel NF: Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 2003, 349:1113-1122
57. Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ: Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci USA 2009, 106:8683-8688
58. Tang Z, Iqbal M, Cawthon D, Bottje WG: Heart and breast muscle mitochondrial dysfunction in pulmonary hypertension syndrome in broilers (Gallus domesticus). Comp Biochem Physiol A Mol Integr Physiol 2002, 132:527-540
59. Cawthon D, Iqbal M, Brand J, McNew R, Bottje WG: Investigation of proton conductance in liver mitochondria of broilers with pulmonary hypertension syndrome. Poult Sci 2004, 83:259-265
60. Ghofrani HA, Seeger W, Grimminger F: Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005, 353:1412-1413
61. Pelicano H, Martin DS, Xu RH, Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646
62. Tofovic SP, Salah EM, Mady HH, Jackson EK, Melhem MF: Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol 2005, 46:430-437
63. Koulmann N, Novel-Chate V, Peinnequin A, Chapot R, Serrurier B, Simler N, Richard H, Ventura-Clapier R, Bigard X: Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy. Am J Respir Crit Care Med 2006, 174:699-705
64. Michelakis ED, McMurtry MS, Wu XC, Dyck JR, Moudgil R, Hopkins TA, Lopaschuk GD, Puttagunta L, Waite R, Archer SL: Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation 2002, 105:244-250